ABOS— Acumen Pharmaceuticals, Inc. Stock Signals & AI Analysis
80
AI Score0
Signals (30d)
80
Avg Score
No signals yet for ABOS
Open Alpha monitors 9 independent data sources. When insider trades, options flow, congressional activity, or other signals fire for ABOS, they'll appear here.
Get full ABOS analysis free
See complete insider trade details, AI analysis, convergence breakdowns, options flow data, and real-time alerts. No credit card required.
Sign Up FreeFree tier includes delayed signals, Live Feed, and community Discord access
Frequently Asked Questions About ABOS
Are insiders buying ABOS stock?
No recent insider purchases detected in the last 30 days for Acumen Pharmaceuticals, Inc. (ABOS). Open Alpha monitors all SEC Form 4 filings in real-time and will alert when insiders at Acumen Pharmaceuticals, Inc. buy or sell shares.
What do congressional trades say about ABOS?
No recent congressional trading activity detected for Acumen Pharmaceuticals, Inc. (ABOS). Open Alpha monitors congressional trade disclosures from both the House and Senate. Note that congressional trades are reported with a 28-45 day delay by law.
Is there unusual dark pool activity on ABOS?
Open Alpha monitors FINRA Reg SHO daily short volume data for Acumen Pharmaceuticals, Inc. (ABOS) and thousands of other tickers. Dark pool short volume ratios above historical averages can indicate institutional positioning. Sign up free to access dark pool monitoring and threshold list alerts for ABOS.
What is the AI conviction score for ABOS?
The highest recent AI conviction score for Acumen Pharmaceuticals, Inc. (ABOS) is 80/100, with an average score of 80/100 across 0 signals in the last 30 days. Open Alpha's convergence engine combines insider trades, options flow, congressional activity, and SEC filings to generate conviction scores from 0-100.
How accurate are trading signals for ABOS?
Not enough tracked outcomes are available yet to calculate a reliable win rate for Acumen Pharmaceuticals, Inc. (ABOS). Open Alpha tracks all signal outcomes over 7-day, 14-day, and 30-day horizons using verified price data from licensed providers. As more signals fire and resolve, accuracy statistics will become available. This is not investment advice.